Skip to content
Disclosery

EXANE DERIVATIVES: MTCH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MTCH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 755 MTCH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 755 shares
    Change vs previous 13F -1,034 shares

    0.03% of the 13F portfolio, value $52,605.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,789 shares
    Change vs previous 13F +272 shares

    0.05% of the 13F portfolio, value $194,524.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,517 shares
    Change vs previous 13F -336 shares

    0.05% of the 13F portfolio, value $200,616.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,853 shares
    Change vs previous 13F -301 shares

    0.07% of the 13F portfolio, value $290,892.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,154 shares
    Change vs previous 13F +68 shares

    0.08% of the 13F portfolio, value $354,562.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,086 shares
    Change vs previous 13F +1,785 shares

    0.09% of the 13F portfolio, value $286,562.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 301 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $45,506.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).